IPCA LABORATORIES
|
|
| BOM : 524494 NSE : IPCALAB | |
| LT :
Long Term Analysis
Fundamentals : Good
Valuation : Average [Stock is fairly valued] Debt : Low |
Updated: |
| ST :
Short Term Analysis
Quarterly Earnings Trend : Neutral
Price Momentum : Mild Upward Pledged Shares : None or < 25% |
Jul 11,2025 |
|
Price(EOD): ₹ 1,449.25
This is the End-of-Day (EOD) Stock Price updated daily by 7 pm IST.
|
Pharmaceuticals & Drugs |
| MCap: ₹ 36,767.47 Cr | |
| Industry Peers & Returns | 1W | 1M | 1Y |
| IPCA LABORATORIES | -0.5% | 4.8% | 18.1% |
| SUN PHARMACEUTICAL INDUSTRIES | -0.4% | -0.9% | 4.8% |
| DIVIS LABORATORIES | -0.7% | 1.6% | 50.2% |
| CIPLA | -1.7% | -1.1% | -2.3% |
| TORRENT PHARMACEUTICALS | -1.1% | 1.6% | 13.7% |
| DR REDDYS LABORATORIES | -4.3% | -8% | -4.4% |
| MANKIND PHARMA | 6.8% | 8% | 20.9% |
| ZYDUS LIFESCIENCES | -1.9% | 0.1% | -16.5% |
| LUPIN | -4.3% | -6.4% | 4.6% |
FUNDAMENTAL ANALYSIS OF IPCA LABORATORIES
[ Q(TTM): Mar2025, Y: Mar2025
Q : Last Qtr data
Y : Last Audited Annual/Yearly Data
TTM i.e. Trailing Twelve Months is calculated using last 4 quarterly data and is a good substitute to track last 4 Qtr Annual result before the subsequent year data is published and audited.
Learn More
]Y : Last Audited Annual/Yearly Data
TTM i.e. Trailing Twelve Months is calculated using last 4 quarterly data and is a good substitute to track last 4 Qtr Annual result before the subsequent year data is published and audited.
Learn More
VALUATION OF IPCA LABORATORIES
[As on : Jul 11,2025
]
| Ratio | Consolidated | |
|---|---|---|
|
P/E P/B P/S |
46.69
P/E Calculated based on Trailing Twelve Months (TTM) Earnings of Rs 787.53 Cr
[Latest Qtr - Mar2025 - Consolidated Results ] 5.29
P/B Calculated based on Book Value of Rs 6,945.75 Cr
[Latest Year - Mar2025 - Consolidated Results ] 4.11
P/S Calculated based on Trailing Twelve Months (TTM) Revenues of Rs 8,939.59 Cr
[Latest Qtr - Mar2025 - Consolidated Results ] |
|
| Financial Ratios → | ||
| Model | Discount(-)/ Premium(+) |
|---|---|
|
EV/EBIDTA EV/Sales Price/Sales |
81% 12% 10% |
SHARE PRICE MOMENTUM OF IPCA LABORATORIES
IPCA LABORATORIES vs SENSEX
DEBT OF IPCA LABORATORIES
| Year | Debt/Equity ratio | |
|---|---|---|
| Standalone | Consolidated | |
|
2025 2024 2023 Avg_3yrs |
0.13 0.18 0.24 0.18 |
0.19 0.22 0.25 0.22 |
|
[Last Annual Data : Mar2025]
|
||
| Financial Ratios → | ||
PLEDGED PROMOTER SHARES OF IPCA LABORATORIES
| Pledged Promoter Shares |
0 % | |
|---|---|---|
| As on : Mar2025 | ||
If less than 25% | Good |
|
| If between 25% and 50% | Neutral | |
| If greater than 50% | Bad | |
| Shareholding Pattern → | ||
QTRLY RESULTS OF IPCA LABORATORIES
| Consolidated | Q-o-Q | Y-o-Y |
|---|---|---|
|
Revenue Op Profit Profit Before Tax Profit After Tax |
0.06% -7.39% -65.21% -76.28% |
10.51% 33.23% 67.1% 2160.48% |
| QtrlyTrend |
2 | |
| Latest Qtr: Mar2025 | ||
| Quarterly Result Analysis → | ||
IPCA LABORATORIES related INDICES
| BSE Indices | 1W | 1M | 1Y |
|---|---|---|---|
| BSE ALLCAP | 6.4% | 8.9% | 7.5% |
| BSE MIDSMALLCAP | 4.7% | 9% | 8.4% |
| BSE LARGEMIDCAP | 4.5% | 7.2% | 8.3% |
| BSE 500 SHARIAH | 4.3% | 4.3% | 1.1% |
| BSE 400 MIDSMALLCAP INDEX | -1.1% | -0.1% | -0.8% |
| NSE Indices | 1W | 1M | 1Y |
|---|---|---|---|
| NIFTY 500 EQUAL WEIGHT | -0.7% | -0.3% | -0.3% |
| NIFTY PHARMA | -0.7% | 0.8% | 9.4% |
| NIFTY MIDSMALL HEALTHCARE | -1.1% | 3% | 19.8% |
| NIFTY500 LARGEMIDSMALL EQUAL-CAP WEIGHTED INDEX | -1.1% | -0.2% | 1.2% |
| NIFTY500 MULTICAP 50:25:25 | -1.1% | -0.2% | 1.3% |
You may also like the below Video Courses
FAQ about IPCA LABORATORIES
Is IPCA LABORATORIES good for long term investment?
As on Jul 11,2025, the Fundamentals of IPCA LABORATORIES look Strong and hence it may be good for long term investment! See Financial Performance of IPCA LABORATORIES . Please look at the other parameters such as Valuation, Price Momentum, News & Corporate Governance and/or consult an Investment Advisor before taking an investment decision!Is IPCA LABORATORIES UnderValued or OverValued?
As on Jul 11,2025, IPCA LABORATORIES is Fairly Valued based on the estimates of intrinsic value and investors may wait for the buying opportunity once it becomes under valued!What is the Intrinsic Value of IPCA LABORATORIES ?
As on Jul 11,2025, the Intrinsic Value of IPCA LABORATORIES is Rs. 1,290.95 estimated based on Median of the 3 historical models.Fair Value [Median EV / EBIDTA Model] : Rs. 802.06
Fair Value [Median EV / Sales Model] : Rs. 1,290.95
Fair Value [Median Price / Sales Model] : Rs. 1,320.88
Estimated Median Fair Value of IPCA LABORATORIES : Rs. 1,290.95
The fair value of any stock is always subjective and should, in no way, be taken as a recommendation to buy/sell the same.
